Press Releases

Grant funds chemotherapy-free breast cancer therapy researchSep 21, 2017
A new grant to Baylor College of Medicine from the Department of Defense advances effort to develop effective treatments for HER2-positive breast cancers without chemotherapy.
Grant funds chemotherapy-free breast cancer therapy researchSep 21, 2017
A new grant to Baylor College of Medicine from the Department of Defense advances effort to develop effective treatments for HER2-positive breast cancers without chemotherapy.
Gut microbes might help prevent, treat colorectal cancerSep 13, 2017
The gut microbiome might one day help prevent and treat colorectal cancer, according to researchers at Baylor College of Medicine, Texas Children’s Hospital and Columbia University.
DNA looping may lead to opportunities to treat brain tumorsSep 11, 2017
The discovery of a mechanism by which normal brain cells regulate the expression of the NFIA gene might one day help improve therapies to treat brain tumors.
Device accurately identifies cancer in seconds during surgerySep 6, 2017
A new handheld device rapidly and accurately identifies cancerous tissue during surgery, delivering results in about 10 seconds.
CPRIT awards $13M for prevention, research, recruitmentAug 18, 2017
Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
CPRIT awards $13M for prevention, research, recruitmentAug 18, 2017
Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
CPRIT awards $13M for prevention, research, recruitmentAug 18, 2017
Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
CPRIT awards $13M for prevention, research, recruitmentAug 18, 2017
Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
Grant to compare large-scale genomic sequencing, standard clinical tests for childhood cancer patientsAug 8, 2017
Baylor’s KidsCanSeq program will compare the results of large-scale genomic testing to targeted clinical tests in childhood cancer patients.
Grant to compare large-scale genomic sequencing, standard clinical tests for childhood cancer patientsAug 8, 2017
Baylor’s KidsCanSeq program will compare the results of large-scale genomic testing to targeted clinical tests in childhood cancer patients.
St. Baldrick’s awards eight faculty with cancer research grantsJul 27, 2017
The St. Baldrick’s Foundation has announced its 2017 summer grant recipients, including eight from Baylor College of Medicine.
St. Baldrick’s awards eight faculty with cancer research grantsJul 27, 2017
The St. Baldrick’s Foundation has announced its 2017 summer grant recipients, including eight from Baylor College of Medicine.
How CD44s gives brain cancer survival advantageJul 18, 2017
In the case of glioblastoma multiforme, researchers have discovered that the molecule CD44s seems to give cancer cells a survival advantage.
Baylor named site for NCI proteogenomics analysis, researchJun 27, 2017
The Lester and Sue Smith Breast Center was named the only Proteogenomic Translational Research Center site in the South.
Genomic sequencing may benefit parents of cancer patientsJun 26, 2017
Researchers report that genomic sequencing information may be more valuable for families of pediatric cancer patients than has previously been recognized.
Newly revealed cellular pathway may lead to cancer therapiesJun 15, 2017
Scientists have discovered a new cellular pathway that can promote and support the growth of cancer cells.
Analyses of liver cancer reveals unexpected genetic playersJun 15, 2017
Researchers analyzed 363 liver cancer cases to learn more about the genetic causes of this cancer, and to identify potential new therapeutic targets.
Annual Metastatic Breast Cancer Conference seeks abstractsMay 22, 2017
The Metastatic Breast Cancer Conference is currently seeking abstracts for consideration at the annual conference on Oct. 12 – 13, 2017 at Baylor College of Medicine.
Cancer study assesses targets for personalized medicineMay 18, 2017
A study confirmed previously known cancer molecular changes and discovered others that had not been typically linked to cancer before.